BeOne Medicines (ONC) Cash & Equivalents (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.37% |
| Dec 31, 2025 | 12.65% |
| Sep 30, 2025 | 46.47% |
| Jun 30, 2025 | 9.52% |
| Mar 31, 2025 | -4.22% |
| Dec 31, 2024 | -2.76% |
| Sep 30, 2024 | 4.21% |
| Jun 30, 2024 | -7.19% |
| Mar 31, 2024 | -11.93% |
| Dec 31, 2023 | 3.41% |
| Sep 30, 2023 | -10.06% |
| Jun 30, 2023 | -3.63% |
| Mar 31, 2023 | -8.55% |
| Dec 31, 2022 | 2,025,849.74% |
| Sep 30, 2022 | -100.00% |
| Jun 30, 2022 | 1,372,971.82% |
| Mar 31, 2022 | 0.61% |
| Dec 31, 2021 | -99.98% |
| Sep 30, 2021 | -22.13% |
| Jun 30, 2021 | 582,341.97% |
| Mar 31, 2021 | -99.98% |
| Dec 31, 2020 | -5.63% |
| Sep 30, 2020 | 517,380.57% |
| Jun 30, 2020 | 0.35% |
| Mar 31, 2020 | -99.95% |
| Dec 31, 2019 | 4,230.54% |
| Sep 30, 2019 | -2.03% |
| Jun 30, 2019 | -2.23% |
| Mar 31, 2019 | 2.45% |
| Dec 31, 2018 | -0.11% |
| Sep 30, 2018 | -96.68% |
| Jun 30, 2018 | 2,411.00% |
| Mar 31, 2018 | -92.71% |
| Dec 31, 2017 | 14.91% |
| Sep 30, 2017 | -20.11% |
| Jun 30, 2017 | 167.01% |
| Mar 31, 2017 | 11.70% |
| Dec 31, 2016 | 2.32% |
| Sep 30, 2016 | 47.26% |
| Jun 30, 2016 | -72.14% |
| Mar 31, 2016 | 1,066.86% |
| Dec 31, 2015 | -34.90% |
| Sep 30, 2015 | 9.12% |
| Jun 30, 2015 | 88.19% |